BAM vs WST · P/E 31, rev $4.82B vs P/E 35, rev $1.72B
Brookfield Asset Management Ltd. (BAM) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Brookfield Asset Management Ltd. (BAM) is a asset management company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported BAM revenue for 2025-12-31 was $4.82B. Net income was $2.40B. Revenue was up 21.0% from 2024-12-31 to 2025-12-31. BAM currently screens at market cap $78.23B and trailing P/E 31.4.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
BAM currently screens at market cap $78.23B and trailing P/E 31.4. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the BAM and WST stock pages for the full models.
Not investment advice.